Evaluation of clearance mechanisms with transscleral drug delivery
- PMID: 20484583
- DOI: 10.1167/iovs.10-5337
Evaluation of clearance mechanisms with transscleral drug delivery
Abstract
Purpose: The goal of this study was to examine elimination pathways when delivering subconjunctivally administered hydrophilic agents to the retinas of rat eyes.
Methods: The distribution of sodium fluorescein released from an episcleral implant was compared in live and postmortem eyes. Elimination of the subconjunctivally administered hydrophilic agent IgG through blood and lymphatic vessels was investigated by immunohistochemistry. Additionally, lymphatic elimination of subconjunctivally injected sodium fluorescein was quantitatively evaluated.
Results: NaFl released from an episcleral implant was successfully delivered to the subretinal space in the postmortem eye but failed to do so in the live eye. Immunohistochemical visualization of the conjunctival tissue demonstrated dense distribution of blood and lymphatic vessels while also confirming the elimination of subconjunctivally administered IgG through these same vessels. The lymphatic elimination rate after injection of 75.6 μg of a hydrophilic agent, sodium fluorescein, into the subconjunctival space was determined to be 105 ng/min between 30 and 60 minutes.
Conclusions: Conjunctival blood and lymphatic vessel elimination considerably limit transscleral hydrophilic drug delivery to the retina.
Similar articles
-
Episcleral clearance of sodium fluorescein from a bioerodible sub-tenon's implant in the rat.Exp Eye Res. 2010 Apr;90(4):501-6. doi: 10.1016/j.exer.2010.01.001. Epub 2010 Jan 11. Exp Eye Res. 2010. PMID: 20064508 Free PMC article.
-
Delivery from episcleral exoplants.Invest Ophthalmol Vis Sci. 2006 Oct;47(10):4532-9. doi: 10.1167/iovs.06-0030. Invest Ophthalmol Vis Sci. 2006. PMID: 17003449
-
Functional, structural, and molecular identification of lymphatic outflow from subconjunctival blebs.Exp Eye Res. 2020 Jul;196:108049. doi: 10.1016/j.exer.2020.108049. Epub 2020 May 6. Exp Eye Res. 2020. PMID: 32387381 Free PMC article.
-
Lymphatic vessels of the eye - old questions - new insights.Ann Anat. 2019 Jan;221:1-16. doi: 10.1016/j.aanat.2018.08.004. Epub 2018 Sep 18. Ann Anat. 2019. PMID: 30240907 Review.
-
Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.Adv Drug Deliv Rev. 2006 Nov 15;58(11):1164-81. doi: 10.1016/j.addr.2006.07.025. Epub 2006 Sep 16. Adv Drug Deliv Rev. 2006. PMID: 17069929 Review.
Cited by
-
Compartmental and COMSOL Multiphysics 3D Modeling of Drug Diffusion to the Vitreous Following the Administration of a Sustained-Release Drug Delivery System.Pharmaceutics. 2021 Nov 4;13(11):1862. doi: 10.3390/pharmaceutics13111862. Pharmaceutics. 2021. PMID: 34834276 Free PMC article.
-
Delivery of intraocular triamcinolone acetonide in the treatment of macular edema.Pharmaceutics. 2012 Mar 15;4(1):230-42. doi: 10.3390/pharmaceutics4010230. Pharmaceutics. 2012. PMID: 24300190 Free PMC article.
-
Enhanced immune responses to vaccine antigens in the corneal stroma.J Control Release. 2023 Jan;353:434-446. doi: 10.1016/j.jconrel.2022.11.045. Epub 2022 Dec 7. J Control Release. 2023. PMID: 36462639 Free PMC article.
-
Recent achievements in nano-based technologies for ocular disease diagnosis and treatment, review and update.J Nanobiotechnology. 2022 Aug 2;20(1):361. doi: 10.1186/s12951-022-01567-7. J Nanobiotechnology. 2022. PMID: 35918688 Free PMC article. Review.
-
Protein and polypeptide mediated delivery to the eye.Adv Drug Deliv Rev. 2022 Sep;188:114441. doi: 10.1016/j.addr.2022.114441. Epub 2022 Jul 9. Adv Drug Deliv Rev. 2022. PMID: 35817213 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources